A relapszus-remisszio korformaju sclerosis multiplex kezelese

Translated title of the contribution: Therapy of relapsing-remitting multiple sclerosis

K. Bencsik, C. Rajda, P. Klivenyi, T. Jardanhazy, M. Torok, L. Vecsei

Research output: Contribution to journalReview article

Abstract

Thanks to the multicentre, double-blind, randomized, placebo-controlled clinical trials in the last 5 years a significant progress in the therapy of relapsing-remitting multiple sclerosis was achieved. The aim of steroid therapy is to reduce the rate of acute exacerbations. The first-choice recommended therapeutical strategy is the megadosis steroid therapy according to the Longitudinal Optic Neuritis Study. Drugs are available nowaday to reduce the progression of the disease: interferon-β-1a interferon-β-1b and glatirameracetate. The new therapeutic possibilities provide us to slow down the progression of multiple sclerosis and to delay the worsening of patient's condition.

Translated title of the contributionTherapy of relapsing-remitting multiple sclerosis
Original languageHungarian
Pages (from-to)756-760
Number of pages5
JournalLege Artis Medicinae
Volume8
Issue number11
Publication statusPublished - Dec 1 1998

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Therapy of relapsing-remitting multiple sclerosis'. Together they form a unique fingerprint.

  • Cite this